Choice of treatment and adherence to international ESO-ESMO (ABC) guidelines in HR+/HER2-ve metastatic breast cancer (MBC) patients (pts). RADICAL trial: A phase Ib/IIa study to assess the safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results